Meera Narasimhan

1.9k total citations
49 papers, 1.3k citations indexed

About

Meera Narasimhan is a scholar working on Psychiatry and Mental health, Pharmacology and Social Psychology. According to data from OpenAlex, Meera Narasimhan has authored 49 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Psychiatry and Mental health, 10 papers in Pharmacology and 7 papers in Social Psychology. Recurrent topics in Meera Narasimhan's work include Schizophrenia research and treatment (18 papers), Bipolar Disorder and Treatment (13 papers) and Treatment of Major Depression (8 papers). Meera Narasimhan is often cited by papers focused on Schizophrenia research and treatment (18 papers), Bipolar Disorder and Treatment (13 papers) and Treatment of Major Depression (8 papers). Meera Narasimhan collaborates with scholars based in United States, India and Canada. Meera Narasimhan's co-authors include Robert Berman, Prakash S. Masand, Dennis S. Charney, Melissa Harris, Nashaat N. Boutros, Gerard Sanacora, Ralph E. Hoffman, Philip D. Harvey, Richard S.E. Keefe and Seithikurippu R. Pandi‐Perumal and has published in prestigious journals such as Biological Psychiatry, Schizophrenia Bulletin and Schizophrenia Research.

In The Last Decade

Meera Narasimhan

49 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meera Narasimhan United States 21 557 222 202 187 179 49 1.3k
Chia Liu Taiwan 21 500 0.9× 223 1.0× 75 0.4× 139 0.7× 98 0.5× 52 1.3k
Joachim Cordes Germany 20 722 1.3× 297 1.3× 255 1.3× 361 1.9× 214 1.2× 51 1.6k
Prasad R. Padala United States 23 621 1.1× 301 1.4× 159 0.8× 209 1.1× 170 0.9× 81 1.6k
Harris A. Eyre Australia 21 479 0.9× 243 1.1× 293 1.5× 358 1.9× 240 1.3× 85 2.3k
Jennifer Hoblyn United States 17 935 1.7× 266 1.2× 78 0.4× 179 1.0× 243 1.4× 32 1.4k
Nadine Dougall United Kingdom 29 675 1.2× 563 2.5× 230 1.1× 322 1.7× 304 1.7× 78 2.1k
Kyung‐Yeol Bae South Korea 32 567 1.0× 220 1.0× 196 1.0× 618 3.3× 268 1.5× 102 2.7k
Paula Villela Nunes Brazil 22 910 1.6× 198 0.9× 113 0.6× 213 1.1× 74 0.4× 73 1.7k
Joaquim Cerejeira Portugal 14 682 1.2× 134 0.6× 149 0.7× 241 1.3× 98 0.5× 37 1.9k
Cássio M. C. Bottino Brazil 19 738 1.3× 312 1.4× 123 0.6× 187 1.0× 90 0.5× 47 1.5k

Countries citing papers authored by Meera Narasimhan

Since Specialization
Citations

This map shows the geographic impact of Meera Narasimhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meera Narasimhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meera Narasimhan more than expected).

Fields of papers citing papers by Meera Narasimhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meera Narasimhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meera Narasimhan. The network helps show where Meera Narasimhan may publish in the future.

Co-authorship network of co-authors of Meera Narasimhan

This figure shows the co-authorship network connecting the top 25 collaborators of Meera Narasimhan. A scholar is included among the top collaborators of Meera Narasimhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meera Narasimhan. Meera Narasimhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Madathil, Kapil Chalil, et al.. (2024). Technological barriers to providing pediatric mental and behavioral healthcare in emergency departments. Applied Ergonomics. 125. 104426–104426. 1 indexed citations
3.
Cai, Chao, Chris M Kozma, Charmi Patel, et al.. (2024). Adherence, health care utilization, and costs between long-acting injectable and oral antipsychotic medications in South Carolina Medicaid beneficiaries with schizophrenia. Journal of Managed Care & Specialty Pharmacy. 30(6). 549–559. 4 indexed citations
4.
Pandi‐Perumal, Seithikurippu R., Vijay Kumar Chattu, Nevin F. W. Zaki, et al.. (2021). ‘Distant socializing,’ not ‘social distancing’ as a public health strategy for COVID-19. Pathogens and Global Health. 115(6). 357–364. 10 indexed citations
5.
Harvey, Philip D., William P. Horan, Alexandra S. Atkins, et al.. (2020). Factor structure of cognitive performance and functional capacity in schizophrenia: Evidence for differences across functional capacity measures. Schizophrenia Research. 223. 297–304. 11 indexed citations
6.
Keefe, Richard S.E., et al.. (2016). Validation of a Computerized test of Functional Capacity. Schizophrenia Research. 175(1-3). 90–96. 60 indexed citations
7.
Atkins, Alexandra S., Elizabeth W. Twamley, Philip D. Harvey, et al.. (2016). Validation of the tablet-administered Brief Assessment of Cognition (BAC App). Schizophrenia Research. 181. 100–106. 54 indexed citations
8.
Patkar, Ashwin A., Chi‐Un Pae, Paul A. Vöhringer, et al.. (2015). A 13-Week, Randomized Double-Blind, Placebo-Controlled, Cross-Over Trial of Ziprasidone in Bipolar Spectrum Disorder. Journal of Clinical Psychopharmacology. 35(3). 319–323. 11 indexed citations
9.
Green, Alan I., Mary F. Brunette, Ree Dawson, et al.. (2015). Long-Acting Injectable vs Oral Risperidone for Schizophrenia and Co-Occurring Alcohol Use Disorder. The Journal of Clinical Psychiatry. 76(10). 1359–1365. 34 indexed citations
10.
BaHammam, Ahmed S., Tetyana Kendzerska, Ravi Gupta, et al.. (2015). Comorbid depression in obstructive sleep apnea: an under-recognized association. Sleep And Breathing. 20(2). 447–456. 91 indexed citations
11.
Hoagwood, Kimberly, Susan M. Essock, J Morrissey, et al.. (2015). Use of Pooled State Administrative Data for Mental Health Services Research. Administration and Policy in Mental Health and Mental Health Services Research. 43(1). 67–78. 11 indexed citations
12.
Keefe, Richard S.E., Vicki G. Davis, Dana Hilt, et al.. (2014). Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale. European Neuropsychopharmacology. 25(2). 176–184. 48 indexed citations
13.
Narasimhan, Meera, et al.. (2010). Treating depression and achieving remission. Asian Journal of Psychiatry. 3(4). 163–168. 1 indexed citations
14.
Harding, Richard, et al.. (2010). Simplifying Adherence in Schizophrenia. Psychiatric Services. 61(4). 405–408. 20 indexed citations
15.
Mabe, P. Alex, et al.. (2009). Immersing Practitioners in the Recovery Model: An Educational Program Evaluation. Community Mental Health Journal. 45(4). 239–245. 32 indexed citations
16.
Narasimhan, Meera, et al.. (2008). Delirium and antipsychotics: a systematic review of epidemiology and somatic treatment options.. PubMed. 5(10). 29–36. 37 indexed citations
17.
Narasimhan, Meera, et al.. (2007). Review of olanzapine in the management of bipolar disorders.. PubMed. 3(5). 579–87. 23 indexed citations
18.
Harris, Melissa, et al.. (2007). Psychogenic polydipsia review: Etiology, differential, and treatment. Current Psychiatry Reports. 9(3). 236–241. 96 indexed citations
19.
Narasimhan, Meera, et al.. (2006). Partial compliance with antipsychotics and its impact on patient outcomes. International Journal of Psychiatry in Clinical Practice. 11(2). 102–111. 21 indexed citations
20.
Masand, Prakash S. & Meera Narasimhan. (2006). Improving Adherence to Antipsychotic Pharmacotherapy. Current Clinical Pharmacology. 1(1). 47–56. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026